We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rapid UTI Test System Combines an Immunoassay with a Smartphone Camera

By LabMedica International staff writers
Posted on 22 Jan 2020
Print article
Image: A smartphone camera is an important component of a new assay system for the detection of E. coli in urine samples (Photo courtesy of University of Bath)
Image: A smartphone camera is an important component of a new assay system for the detection of E. coli in urine samples (Photo courtesy of University of Bath)
A team of British bioengineers has combined a rapid microfluidic fluorescence sandwich immunoassay with a smartphone camera to form an assay system for the diagnosis of urinary tract infections (UTIs).

In its initial configuration, the assay is set to detect the bacterium Escherichia coli, which is found in about 80% of bacterial UTIs.

The test, as designed by investigators at the University of Bath (United Kingdom), is performed by passing a urine sample over a ridged plastic micro-capillary strip, to which are bound immobilized antibodies able to recognize E. coli bacteria. If E. coli are present in the sample, the antibodies will bind to them, preventing the bacteria from passing through that section of the plastic strip. An enzyme is added that causes a change in color that can be recorded by the smartphone camera. An application determines the concentration of E. coli in the sample by analyzing the image taken by the camera.

A prototype of the system operating with E. coli in synthetic urine was shown to be able to detect a minimal concentration of 240 CFU/mL (colony forming units per milliliter) of bacteria, compatible with cut-off levels for UTIs. The test took less than 25 minutes and did not require any sample preparation or concentration.

Senior author Dr. Nuno Reis, reader in the department of chemical engineering at the University of Bath, said, "The test is small and portable - so it has major potential for use in primary care settings and in developing countries. Currently, bacterial infections in UTIs are confirmed via microbiological testing of a urine sample. That is accurate, but time-consuming, taking several days. We hope that giving medical professionals the ability to quickly rule in or rule out certain conditions will allow them to treat patients more quickly and help them make better decisions about the prescription of antibiotics. The smartphone solves one of the biggest problems of the decentralizing of diagnostics because their capabilities are actually very sophisticated in certain conditions. They offer the same functionality as sophisticated scanners that have until now been available only in labs."

The rapid UTI test was described in the December 1, 2019, online edition of the journal Biosensors and Bioelectronics.

Related Links:
University of Bath

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more